Yuping Li Selected Research

Yuping Li Research Topics

Disease

26	Neoplasms (Cancer) 10/2022 - 01/2005
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2016
8	Infections 10/2022 - 01/2013
7	Acute Lung Injury 06/2022 - 08/2011
7	Chronic Obstructive Pulmonary Disease (COPD) 02/2021 - 01/2014
6	Inflammation (Inflammations) 12/2022 - 01/2014
6	Pneumonia (Pneumonitis) 02/2022 - 01/2016
6	Adenocarcinoma of Lung 01/2022 - 01/2008
6	Lung Neoplasms (Lung Cancer) 03/2020 - 09/2015
5	Neoplasm Metastasis (Metastasis) 11/2022 - 12/2007
5	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022 - 01/2014
4	Disease Progression 11/2022 - 01/2021
4	Brain Neoplasms (Brain Tumor) 04/2022 - 11/2021
4	Lung Injury 02/2022 - 08/2011
4	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 08/2014
4	COVID-19 02/2021 - 01/2020
4	Hematoma 02/2020 - 12/2018
3	Obesity 03/2022 - 09/2009
3	Neuralgia (Stump Neuralgia) 01/2022 - 11/2017
3	Glioma (Gliomas) 01/2022 - 08/2014
3	Cognitive Dysfunction 07/2021 - 10/2016
3	Hypoxia (Hypoxemia) 01/2016 - 06/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2012 - 11/2002
2	Sepsis (Septicemia) 12/2022 - 10/2022
2	Wounds and Injuries (Trauma) 04/2022 - 10/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2021
2	Lymphoma (Lymphomas) 01/2022 - 12/2020
2	Chronic Cough 12/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2021
2	Leukemia 10/2021 - 07/2015
2	Ischemic Stroke 05/2020 - 01/2019
2	Hypertensive Intracranial Hemorrhage 02/2020 - 12/2018
2	Hypertension (High Blood Pressure) 10/2019 - 02/2014
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
7	ErbB Receptors (EGF Receptor)IBA 04/2022 - 01/2016
6	LipopolysaccharidesIBA 06/2022 - 01/2014
5	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2012
5	Tyrosine Kinase InhibitorsIBA 11/2022 - 01/2016
5	Neuroprotective AgentsIBA 05/2020 - 10/2016
5	SmokeIBA 01/2020 - 01/2014
4	Gefitinib (Iressa)FDA Link 11/2022 - 08/2017
4	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2021
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2018
4	CytokinesIBA 01/2021 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2016
3	ProcalcitoninIBA 10/2022 - 06/2019
3	Therapeutic UsesIBA 06/2022 - 08/2011
3	Circulating Tumor DNAIBA 04/2022 - 01/2017
3	EnzymesIBA 02/2022 - 01/2005
3	Connexin 43 (Connexin43)IBA 01/2022 - 01/2018
3	AntioxidantsIBA 01/2022 - 01/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 10/2016
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2020 - 01/2005
3	Oxygen (Dioxygen)IBA 09/2019 - 12/2007
3	AlloxanIBA 05/2012 - 11/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008 - 01/2005
2	Long Noncoding RNAIBA 12/2022 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 10/2022 - 07/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 06/2019
2	LipidsIBA 03/2022 - 09/2009
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 03/2022 - 03/2021
2	Sincalide FDA Link 01/2022 - 07/2015
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2021
2	AfatinibIBA 01/2022 - 10/2021
2	Liposomes (Liposome)IBA 01/2022 - 10/2021
2	SiliconesIBA 01/2022 - 03/2018
2	pyrotinibIBA 01/2022 - 01/2022
2	Purinergic P2X3 ReceptorsIBA 12/2021 - 01/2020
2	GefapixantIBA 12/2021 - 01/2020
2	Peptides (Polypeptides)IBA 10/2021 - 01/2014
2	Acetates (Acetic Acid Esters)FDA Link 07/2021 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2021 - 06/2010
2	AntigensIBA 04/2021 - 06/2008
2	B7-H1 AntigenIBA 03/2021 - 01/2021
2	Thalidomide (Thalomid)FDA Link 02/2021 - 06/2020
2	GlucocorticoidsIBA 02/2021 - 06/2020
2	Vancomycin FDA LinkGeneric 01/2021 - 11/2014
2	PlatinumIBA 01/2021 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 04/2019
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2019
2	icotinibIBA 03/2020 - 04/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 11/2016
2	CrizotinibIBA 01/2020 - 08/2017
2	QuercetinIBA 01/2019 - 01/2017

Therapy/Procedure

23	Therapeutics 11/2022 - 08/2011
6	Drug Therapy (Chemotherapy) 04/2022 - 08/2017
4	Length of Stay 02/2020 - 01/2016
2	Immunotherapy 03/2022 - 01/2022
2	Laminectomy 02/2022 - 01/2019
2	Stents 01/2022 - 03/2018
2	Operative Time 03/2021 - 01/2019
2	Transplantation 01/2021 - 11/2017
2	Decompressive Craniectomy 01/2021 - 01/2020
2	Craniotomy 02/2020 - 06/2019
2	Noninvasive Ventilation 09/2019 - 09/2015